Pathogenesis of cholesterol gallstones: A parsimonious hypothesis

European Journal of Clinical Investigation

Volumn 26, Issue 5, 1996, Pages 343-352

  Apstein, M D ^b   Carey, M C ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GRECC and Urology Divisions   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE SALT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN;

CHOLESTASIS; CHOLESTEROL METABOLISM; CHOLESTEROL STONE; CRYSTALLIZATION; GALLBLADDER MOTILITY; MUCUS SECRETION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STONE FORMATION;

EID: 0029899036     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.148287.x     Document Type: Review

References (140)

1. Carey MC, LaMont JT. Cholesterol gallstone formation. 1. Physical-chemistry of bile and biliary lipid secretion. Prog Liver Dis 1992;10:139-63.
2. LaMont JT, Carey MC. Cholesterol gallstone formation. 2. Pathobiology and pathomechanics. Prog Liver Dis 1992;10: 165-91.
3. Apstein MD, Carey MC. Biliary tract stones and associated diseases. In: Stein JH, ed. Internal Medicine, 4th edn. St. Louis: Mosby Yearbook, 1993;646-62.
4. Apstein MD, Carey MC. Gallstones. In: Branch WT, ed. Office Practice of Medicine. 3rd edn. Philadelphia: W.B. Saunders, 1994;277-95.
5. Carey MC, Duane WC. Enterohepatic circulation. In: Arias IM, Boyer JL. Fausto N, Jakoby WB, Schachter D, Shafritz DA, eds. The Liver, Biology and Pathobiology, 3rd edn. New York: Raven Press, 1994:719-67.
6. Carey MC. Formation of cholesterol gallstones: The new paradigms. In: Paumgartner G, Stiehl A, Gerok W, eds. Trends in Bile Acid Research. Dordrecht: Kluwer, 1989:259-81.
7. Carey MC. Pathogenesis of gallstones. Am J Surg 1993;165: 410-19.
8. Carey MC. Formation and growth of cholesterol gallstones: The new synthesis. In: Leuschner U, Fromm H, eds. Bile Acids - Cholestasis - Gallstones. Lancaster: Kluwer, 1996: 147-75.
9. Khanuja B, Cheah Y-C, Hunt M, Nishina PM, Wang DQ-H, Chen HW, Billheimer JT, Carey MC, Paigen B. Lith 1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. Proc Natl Acad Sci USA 1995;92:7729-33.
10. Paumgartner G, Sauerbruch T. Gallstones - pathogenesis. Lancet 1991;338:1117-21.
11. Carey MC, Cahalane MJ. Whither biliary sludge? Gastroenterology 1988;95:508-23.
12. Hoffmann AF. Primary and secondary prevention of gallstone disease: Implications for patient management and research priorities. Am J Surg 1993;165:541-8.
13. Northfield TC, Hofmann AF. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects. Gut 1975;16:1-11.
14. Afdhal NH, Carey MC. New perspectives on gallstone pathogenesis and prevention. J Ir Coll Phys Surg 1995;24:267-78.
15. Jazrawi RP, Pazzi P, Petroni ML et al. Postprandial gallbladder motor function: Refilling and turnover of bile in health and cholelithiasis. Gastroenterology 1995;109:582-91.
16. Vlahcevic ZR, Bell CC, Buhac I, Farrar JT, Swell L. Diminished bile acid pool size in patients with gallstones. Gastroenterology 1970;59:165-73.
17. Behar J, Lee KY, Thompson WR, Biancani P. Gallbladder contraction in patients with pigment and cholesterol stones. Gastroenterology 1989;97:1479-84.
18. Yu PR, Chen Q, Biancani P, Behar J. Excess membrane cholesterol impairs gallbladder muscle contraction. Gastroenterology 1995;108:A442. (Abstract).
19. Behar J, Rhim BY, Thompson W, Biancani P. Inositol triphosphate restores impaired human gallbladder motility associated with cholesterol stones. Gastroenterology 1993;104:563-8.
20. Groen AK, Tytgat GNJ. Role of nucleation influencing factors in the pathogenesis of cholesterol gallstone disease. In: Tytgat GNJ, von Blankenstein M, eds. Current Topics in Gastroenterology and Hepatology. New York: Georg Thieme, 1990: 415-21.
21. Harvey PRC, Upadhya GA, Strasberg SM. Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones. J Biol Chem 1991;266:13996-4003.
22. Upadhya GA, Harvey PRC, Strasberg SM. Effect of human biliary immunoglobulins on the nucleation of cholesterol. J Biol Chem 1993;268:5193-200.
23. deBruijn MAC, Mok KS, Domingo N, Lafont H, Tytgat GNJ, Groen AK. Further characterization of the cholesterol crystallization promoting lipoprotein in biliary Con-A binding proteins (abstract). Gastroenterology 1992;102:A310.
24. deBruijn MAC. Crystallization promoting factors in cholesterol gallstones. PhD thesis. University of Amsterdam. 1994: 87-108.
25. Sampliner RE, Bennett PH, Comess LJ, Rose FA, Burch TA. Gallbladder disease in Pima Indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med 1970;283:1358-64.
26. Pedreira F, Tepperman J. Bile flow rate and cholesterol content in mice fed a gallstone-inducing diet. Am J Physiol 1964;206: 635-40.
27. Dam H. Determinants of cholesterol cholelithiasis in man and animals. Am J Med 1971;51:596-613.
28. Khallou J, Riottot M, Parquet M, Verneau C, Lutton C. Biodynamics of cholesterol and bile acids in the lithiasic hamster. Br J Nutr 1991;66:479-92.
29. Valdivieso V, Palma R, Nervi F, Covarrubias C, Severín C, Antezana C. Secretion of biliary lipids in young Chilean women with cholesterol gallstones. Gut 1979;20:997-1000.
30. Leiss O, von Bergman K, Gnasso A, Augustin J. Effect of Gemfibrozil on biliary lipid metabolism in normolipidemic subjects. Metabolism 1985;34:74-82.
31. Reuben A, Maton PN, Murphy GM, Dowling RH. Bile lipid secretion in obese and non-obese individuals with and without gallstones. Clin Sci 1985;69:71-79.
32. Shaffer EA, Small DM. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest 1977;59:828-840.
33. Grundy SM, Metzger AL, Adler RD. Mechanisms of lithogenic bile formation in American Indian women with cholesterol gallstones. J Clin Invest 1972;51:3026-43.
34. Kern F Jr. Effects of dietary cholesterol on cholesterol and bile acid homeostasis in patients with cholesterol gallstones. J Clin Invest 1994;93:1186-94.
35. Grundy SM, Duane WC, Alder RD, Aron JM, Metzger AL. Biliary lipid outputs in young women with cholesterol gallstones. Metabolism 1974;23:67-73.
36. Carey MC, O'Donovan JM. Gallstone disease: Current concepts on the epidemiology, pathogenesis and management. In: Petersdorf RG, Adams RD, Braunwald E, Isselbacher KJ, Martin JB, Wilson JD, eds. Harrison's Principles of Internal Medicine (Update V). New York: McGraw-Hill, 1984:139-68.
37. Kesäniemi YA, Koskenvuo M, Vuoristo M, Miettinen TA. Biliary lipid composition in monozygotic and dizygotic pairs of twins. Gut 1989;30:1750-6.
38. Danzinger RG, Gordon J, Schoenfield LJ, Thistle JL. Lithogenic bile in siblings of young women with cholelithiasis. Mayo Clin Proc 1972;47:762-6.
39. Van der Linden W. Genetic factors in gallstone disease. Clin Gastroenterol 1973;2:603-14.
40. Gilat T, Feldman C, Halpern Z, Dan M, Bar-Meir S. An increased familial frequency of gallstones. Gastroenterology 1993;84:242-6.
41. Sarin SK, Negi VS, Dewan R, Sasan S, Saraya A. High familial prevalence of gallstones in the first-degree relatives of gallstone patients. Hepatology 1995;22:138-41.
42. O'Brien SJ, Womack JE, Lyons LA, Moore KJ, Jenkins NA, Coreland NG. Anchored reference loci for comparative genome mapping in mammals. Nature Genet 1993;3:103-12.
43. Smith JL, Hardie IR, Pillay SP, de Jersey J. Hepatic acylcoenzyme A: Cholesterol acyltransferase activity is decreased in patients with cholesterol gallstones. J Lipid Res 1990;31: 1993-2000.
44. Puglielli L, Rigotti A, Greco AV, Santos MJ, Nervi F. Sterol carrier protein-2 is involved in cholesterol transfer from the endoplasmic reticulum to the plasma membrane in human fibroblasts. J Biol Chem 1995;270:18723-6.
45. Kawata S, Imai Y, Inada M et al. Modulation of cholesterol 7-α-hydroxylase activity by non-specific lipid transfer protein in human liver -possibly altered regulation of its cytosolic level in patients with gallstones. Clin Chim Acta 991;197:201-8.
46. 2) gene expression in rat peripheral macrophages during foam cell formation. J Clin Invest 1994;94:2215-23.
47. Glickman RM, Sabesin SM. Lipoprotein metabolism. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schacter D, Shafritz DA, eds. The Liver: Biology and Pathobiology. 3rd edn. New York: Raven Press, 1994:391-414.
48. Sahlin S, Ahlberg J, Reihnér E, Ståhlberg D, Einarsson K. Cholesterol metabolism in human gallbladder mucosa: Relationship to cholesterol gallstone disease and effects of chenodeoxycholic acid and ursodeoxycholic acid treatment. Hepatology 1992;16:320-6.
49. Shoda J, He BF, Tanaka N et al. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit. Hepatology 1995;21:1291-302.
50. Salen G, Nicolau G, Shafer S, Mosbach EH. Hepatic cholesterol metabolism in patients with gallstones. Gastroenterology 1975;69:676-84.
51. Coyne MJ, Bonorris GG, Goldstein LJ, Schoenfield LJ. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones. J Lab Clin Med 1976;87:281-91.
52. Maton PN, Ellis HJ, Higgins JP, Dowling RH. Hepatic HMG-CoA reductase in human cholelithiasis: Effects of chenodeoxycholic and ursodeoxycholic acids. Eur J Clin Invest 1980;10: 325-32.
53. Key PH, Bonorris GG, Marks JW, Chung A, Schoenfield LJ. Biliary lipid synthesis and secretion in gallstone patients before and during treatment with chenodeoxycholic acid. J Lab Clin Med 1980;95:816-26.
54. Carulli N, Ponz de Leon M, Zironi F et al. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short-term feeding of chenodeoxycholic and ursodeoxycholic acids. J Lipid Res 1980;21:35-43.
55. Ahlberg J, Angelin B, Einarsson K. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: Relation to cholesterol gallstone disease and effect of cholic and chenodeoxycholic acid treatment. J Lipid Res 1981;22:410-22.
56. Reihner E, Angelin B, Björkhem I, Einarsson K. Hepatic cholesterol metabolism in cholesterol gallstone disease. J Lipid Res 1991;32:469-75.
57. Angelin B, Backman L, Einarsson K, Eriksson L, Ewerth S. Hepatic cholesterol metabolism in obesity: activity of microsomal 3-hydroxy-3-methylglutaryl coenzvme A reductase. J Lipid Res 1982;23:770-773.
58. Akiyoshi T, Uchida K, Takase H, Nomura Y, Takeuchi N. Cholesterol gallstones in alloxan-diabetic mice. J Lipid Res 1986;27:915-24.
59. Kullak-Ublick GA, Paumgartner G, Berr F. Long-term effects of cholecystectomy on bile acid metabolism. Hepatology 1995; 21:41-45.
60. Berr F, Pratschke E, Fischer S, Paumgartner G. Disorders of bile acid metabolism in cholesterol gallstone disease. J Clin Invest 1992;90:859-68.
61. Sitzmann JV, Pitt HA, Steinborn PA, Pasha ZR, Sanders RC. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gynecol Obstet 1990;170:25-31.
62. Van der Werf SDJ, van Berge Henegouwen GP, Palsma DMH, Ruben ATH. Motor function of the gallbladder and cholesterol saturation of duodenal bile. Neth J Med 1987; 30:160-71.
63. Sahlin S, Ståhlberg D, Einarsson K. Cholesterol metabolism in liver and gallbladder mucosa of patients with cholesterolosis. Hepatology 1995;21:1269-75.
64. Pomeranz IS, Shaffer EA. Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology 1985; 88:787-91.
65. Kishk SM, Darweesh RM, Dodds WJ et al. Sonographic evaluation of resting gallbladder volume and postprandial emptying in patients with gallstones. AJR 1987;148:875-879.
66. Small DM, Shipley GG. Physical chemical basis of lipid deposition in atherosclerosis. Science 1974;185:222-9.
67. Neiderhiser DH, Harmon CK, Roth HP. Absorption of cholesterol by the gallbladder. J Lipid Res 1976;17:117-24.
68. Bloom W, Fawcett DW. A Textbook of Histology, 10th edn. Philadelphia: WB Saunders Co. 1975:718-25.
69. Tilvis RS, Aro J, Stranberg TE, Lempinen M, Miettinen TA. Lipid composition of bile and gallbladder mucosa in patients with acalculous cholesterolosis. Gastroenterology 1982;82: 607-15.
70. Metzger AL, Adler R, Heymsfield S, Grundy SM. Diurnal variation in biliary lipid composition. N Engl J Med 1973;288: 333-6.
71. Yu P, Chen Q, Harnett K, Amaral J, Biancani P, Behar J. Direct G-protein activation reverses impaired CCK-signaling in human gallbladders with cholesterol stones. Am J Physiol 1995;269:659-65.
72. Phillips MC. Cholesterol-phospholipid interactions and the exchangeability of cholesterol between membranes. In: Quin PJ, Cherry RJ, eds. Structural and Dynamic Properties of Lipids and Membranes. London: Portland, 1992;103-18.
73. Sanubria JR, Upadhya A, Mullen B, Harvey PRC, Strasberg SM. Effect of deoxycholate on immunoglobulin G concentration in bile: studies in humans and pigs. Hepatology 1995;21: 215-22.
74. Putz P, Willems G. Effect of lithogenic diet on cell proliferation in the murine gallbladder epithelium. Digestion 1981;22:16-23.
75. Wahlin T. Effects of lithogenic diets on mouse gallbladder epithelium. A histochemical, cytochemical and morphometric study. Virchows Arch (B) Cell Pathol 1976;22:273-86.
76. Lee SP, Scott AJ. The evolution of morphologic changes in the gallbladder before stone formation in mice fed a cholesterolcholic acid diet. Am J Pathol 1982;108:1-8.
77. Moody FG, Haley-Russell D, Li YF, Husband KJ, Weisbrodt NW, Dewey RB. The effects of lithogenic bile on gallbladder epithelium. Ann Surg 1989;210:406-16.
78. Haley-Russell D, Husband KJ, Moody FG. Morphology of the prairie dog gallbladder: Normal characteristics and changes during early lithogenesis. Am J Anal 1989;186:133-43.
79. Conter RL, Washington JL, Liao CC, Kauffman GL. Gallbladder mucosal blood flow increases during early cholesterol gallstone formation. Gastroenterology 1992;102:1764-70.
80. Rege RV, Prystowsky JB. Crystalline cholesterol reduces sodium transport in guinea pig gallbladder: An inflammatory response? Gastroenterology 1994;106:968A. (Abstract).
81. Lee SP, Maher K, Nicolls JF. Origin and fate of biliary sludge. Gastroenterology 1988;94:170-6.
82. LaMorte WW, Shoetz DJ, Birkett DH, Williams LF. The role of the gallbladder in the pathogenesis of cholesterol gallstones. Gastroenterology 1979;77:580-92.
83. Heaton KW, Emmett PM, Symes CL, Braddon FEM. An explanation for gallstones in normal-weight women: slow intestinal transit. Lancet 1993;341:8-10.
84. Xu QW, Scott RB, Tan DTM, Shaffer EA. Slow intestinal transit: An added motility disorder in cholesterol gallstone formation (abstract). Gastroenterology 1995;108:A442.
85. Marcus SN, Heaton KW. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile: three inter-related factors. Gut 1986;27:550-8.
86. Ozeki K, Sarna SK, Condon RE, Chey WY, Koch TR. Enterohepatic circulation is essential for regular cycling of duodenal migrating motor complexes in dogs. Gastroenterology 1992;103:759-67.
87. Van Berge Henegouwen GP, Hofmann AF. Nocturnal gallbladder storage and emptying in gallstone patients and healthy subjects. Gastroenterology 1978;75:879-85.
88. Mok HYI, von Bergmann K, Grundy SM. Kinetics of the enterohepatic circulation during fasting: biliary lipid secretion and gallbladder storage. Gastroenterology 1980;78:1023-33.
89. Mok HYI, von Bergmann K, Grundy SM. Regulation of pool size of bile acids in man. Gastroenterology 1977;73:684-90.
90. Thurston OG, McDougall RM, Walker K. The effect of prosthetic gallstones on total bile acid pool size in dogs. Surg Gynecol Obstet 1978;146:911-13.
91. Ho K-J, Ho C, Hsu S, Chen JS. Bile acid pool size in relation to functional status of gallbladder and biliary lipid composition in Chinese. Am J Clin Nutr 1980;33:1026-32.
92. Hay DW, Cahalane MJ, Timofeyeva N, Carey MC. Molecular species of lecithins in human gallbladder biles. J Lipid Res 1993;34:759-68.
93. Swell L, Bell CC, Vlahcevic ZR. Relationship of bile acid pool size to biliary lipid excretion and the formation of lithogenic bile in man. Gastroenterology 1971;61:716-22.
94. Bell CC, Vlahcevic ZR, Prazich J, Swell L. Evidence that a diminished bile acid pool precedes the formation of cholesterol gallstones in man. Surg Gynecol Obstet 1973;136:961-5.
95. Vlahcevic ZR, Bell CC, Gregory DH. Relationship of bile acid pool size to the formation of lithogenic bile in female Indians of the Southwest. Gastroenterology 1972;62:73-83.
96. Hofmann AF, Hoffman NE. Measurement of bile acid kinetics by isotope dilution in man. Gastroenterology 1974;67:314-23.
97. Lanzini A, Jazrawi RP, Northfield TC. Simultaneous quantitative measurements of absolute gallbladder storage and emptying during fasting and eating in humans. Gastroenterology 1987;92:852-61.
98. Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WJ. Nucleation time: A key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979;77: 611-17.
99. de Bruijn MAC, Noordam C, Goldhoorn BG, Tytgat GNJ, Groen AK. The validity of the cholesterol nucleation assay. Biochim Biophys Acta 1992;1138:41-5.
100. Groen AK, Noordam C, Drapers JA, Egbers P, Jansen PL, Tytgat GN. Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile: role in the pathogenesis of gallstone disease. Hepatology 1990;11:525-33.
101. Groen AK, Stout JPJ, Drapers JAG, Hoek FJ, Grijm R, Tytgat GNJ. Cholesterol nucleation-influencing activity in T-tube bile. Hepatology 1988;8:347-52.
102. Offner GD, Gong DH, Afdhal NH. Identification of a 130-kilodalton human biliary concanavalin A binding protein as aminopeptidase N. Gastroenterology 1994;106:755-762.
103. Wang DQ-H, Carey MC. Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiological relevance and identification of a stable liquid chrystalline state in cold, dilute and hydrophilic bile salt-containing systems. J Lipid Res 1996;37:603-30.
104. Wang DQ-H, Carey MC. The complete mapping of cholesterol crystal nucleation paths in model and native biles. Gastroenterology 1994;106:1004. (Abstract).
105. Konikoff FM, Chung DS, Donovan JM, Small DM, Carey MC. Filamentous, helical and tubular microstructures during cholesterol crystallization from bile: Evidence that biliary cholesterol does not nucleate classic monohydrate plates. J Clin Invest 1992;90:1155-60.
106. Konikoff FM, Carey MC. Cholesterol crystallization from a dilute bile salt-rich model bile. J Cryst Growth 1994;144:79-86.
107. Pattinson NR, Willis KE. Nucleation of cholesterol crystals from native bile and the effect of protein hydrolysis. J Lipid Res 1991;32:215-21.
108. Gallinger S, Harvey PRC, Petrunka CN, Ilson RG, Strasberg SM. Biliary proteins and the nucleation defect in cholesterol cholelithiasis. Gastroenterology 1987;92:867-76.
109. Lipsett PA, Fox-Talbot MK, Falconer SD et al. Biliary nonmucin glycoproteins in patients with and without gallstones. J Surg Res 1995;58:386-90.
110. Strasberg SM, Toll JL, Gallinger S, Harvey PRC. High protein and total lipid concentration are associated with reduced metastability of bile in an early stage of cholesterol gallstone formation. Gastroenterology 1990;98:739-46.
111. Holzbach RT, Kibe A, Thiel E, Howell JH, Marsh M, Hermann RE. Biliary proteins. Unique inhibitors of cholesterol crystal nucleation in human gallbladder bile. J Clin Invest 1984;73:35-45.
112. Harvey PRC, Sömjen G, Gilat T, Gallinger S, Strasberg S. Vesicular cholesterol in bile. Relationship to protein concentration and nucleation time. Biochim Biophys Acta 1988;958:10-18.
113. Pattinson NR, Willis KE. Effect of phospholipase-C on cholesterol solubilization in model bile - a concanavalin-A binding nucleation-promoting factor from human gallbladder bile. Gastroenterology 1991;101:1339-44.
114. Chijiiwa K, Koga A, Yamasaki T, Shimada K, Noshiro H, Nakayama F. Fibronectin - a possible factor promoting cholesterol monohydrate crystallization in bile. Biochim Biophys Acta 1991;1086:44-8.
115. Kibe A, Holzbach RT, LaRusso NF, Mao SJT. Inhibition of cholesterol crystal formation by apoproteins in supersaturated model bile. Science 1984;25:514-16.
116. Ahmed HA, Petroni ML, Abu-Hamdiyyah M, Jazrawi RP, Northfield TC. Hydrophobic/hydrophilic balance of proteins: a major determinant of cholesterol crystal formation in model bile. J Lipid Res 1994;35:211-19.
117. Abei M, Schwarzendrube J, Nuutinen H et al. Cholesterol crystallization-promoters in human bile - comparative potencies of immunoglobulins, alpha(1)-acid glycoprotein, phospholipase-C, and aminopeptidase-N. J Lipid Res 1993;34:1141-8.
118. Small DM. Cholesterol nucleation and growth in gallstone formation. N Engl J Med 1980;302:1305-7.
119. Jüngst D, Lang T, von Ritter C, Paumgartner G. Role of high total protein in gallbladder bile in formation of cholesterol gallstones. Gastroenterology 1991;100:1724-29.
120. Bozzoli M, Loria P, Concari M et al. Bile acid (BA) hydrophobicity and biliary secretion of total proteins and immunoglobulins G (IgG) (abstract). Hepatology 1992;16:254A.
121. Levy PR, Smith BF, LaMont JT. Human gallbladder mucin accelerates in vitro nucleation of cholesterol in artificial bile. Gastroenterology 1984;87:270-5.
122. Lee SP, LaMont JT, Carey MC. Role of gallbladder mucin hypersecretion in the evolution of cholesterol gallstones: studies in the prairie dog. J Clin Invest 1981;67:1712-23.
123. Kim YS, Gum JR. Diversity of mucin genes, structure function and expression. Gastroenterology 1995;109:999-1013.
124. Gum Jr JR. Mucin genes and the proteins they encode: Structure, diversity, and regulation. Am J Respir Cell Mol Biol 1992;7:557-64.
125. Wang DQ-H, Paigen B, Carey MC. Phenotypic characterization of Lith genes determining susceptibility to cholesterol gallstone formation in inbred mice. Hepatology 1995;22:289A.
126. O'Leary DP, Murray FE, Turner BS, LaMont JT. Bile salts stimulate glycoprotein release by guinea pig gallbladder in vitro. Hepatology 1991;13:957-61.
127. Carey MC. Physical-chemical properties of bile acids and their salts. In: Danielsson H, Sjövall J, eds. Sterols and Bile Acids (New Comprehensive Biochemistry) Vol. 12. Amsterdam: Elsevier, 1985:345-403.
128. Malet PF, Locke CL, Trotman BW, Soloway RD. The calcium ionophore A 23187 stimulates glycoprotein secretion by the guinea pig gallbladder. Hepatology 1986;6:569-73.
129. Booker ML, Scott TE, LaMorte WW. Effect of dietary cholesterol on phosphatidylcholine and phosphatidylethanolamine in bile and gallbladder mucosa in the prairie dog. Gastroenterology 1989;97:1261-7.
130. Berr F, Schreiber E, Frick U. Interrelations of bile acid and phospholipid fatly acid species with cholesterol saturation of duodenal bile in health and gallstone disease. Hepatology 1992; 16:71-81.
131. Shiffman ML, Sugerman HJ, Kellum JM, Moore EW. Changes in gallbladder bile composition following gallstone formation and weight reduction. Gastroenterology 1992;103: 213-21.
132. Hofmann AF. Bile acid secretion, bile flow, and biliary lipid secretion in humans. Hepatology 1990;12:17S-25S.
133. Carulli N, Loria P, Bertolotti M et al. Effects of acute change of bile acid pool composition on biliary lipid secretion. J Clin Invest 1984;74:614-24.
134. Low-Beer TS, Pomare EW. Can colonie bacterial metabolities predispose to cholesterol gall stones? Br Med J 1995;22:438 40.
135. Afdhal NH, Gong D, Niu N, Turner B, LaMont JT, Offner GB. Cholesterol cholelithiasis in the prairie dog: Role of mucin and non-mucin glycoproteins. Hepatology 1993;17:693-700.
136. Afdhal NH, Niu N, Nunes DP et al. Mucin-vesicle interactions in model bile: Evidence for vesicle aggregation and fusion before cholesterol crystal formation. Hepatology 1995;22: 856-65.
137. Klinkspoor JH, Kuver R, Savard CE et al. Model bile and bile salts accelerate mucin secretion by cultured dog gallbladder epithelial cells. Gastroenterology 1995;109:264-274.
138. Shaffer EA. Motility of the gallbladder and biliary tree. In: 2nd International Conference on Gallstones: Causes and Management - Abstract Booklet. Tel-Aviv: 1995:L5-L6.
139. Berr F, Mayer M, Sackmann MF, Sauerbruch T, Holl J, Paumgartner G. Pathogenic factors in early recurrence of cholesterol gallstones. Gastroenterology 1994;106:215-24.
140. Lowenfels AB. Gallstones and glaciers: The stone that came in from the cold. Lancet 1988;1385-6.